World's leading clinical conference on bone, joint and muscle health
Programme
Thursday April 16th - CEST Timezone
15:30 - 19:00
Auditorium 1
WCO-IOF-ESCEO - OPENING CEREMONY
Chairpersons: Jean-Yves Reginster, Nicholas Harvey
Chairpersons: Jean-Yves Reginster, Nicholas Harvey
15:30
Auditorium 1
Best clinical papers published in 2025
16:10
Auditorium 1
Opening of the Congress
16:20
Auditorium 1
Current global challenges in academic publishing
16:40
Auditorium 1
Presentation of the ESCEO-IOF Pierre Delmas Medal
16:45
Auditorium 1
ESCEO-WHO Innovation Session
17:55
Auditorium 1
Three Years On: Evidence and Insights from the WHO Bone Health Initiative
18:05
Auditorium 1
Presentation of the 2026 IOF CSA Medal of Achievement
18:10
Auditorium 1
Understanding the origin of diseases through population genetics
18:40
Auditorium 1
Presentation of the IOF President's Award
18:45
Auditorium 1
Presentation of the WHO-ESCEO Innovation Award
19:00 - 20:00
Auditorium 1
Welcome Cocktail
Friday April 17th - CEST Timezone
08:00 - 09:00
Auditorium 1
Sponsored Breakfast Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
08:00 - 09:00
Auditorium 2
Sponsored Breakfast Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
08:00 - 09:00
Non-Sponsored Symposia
08:00
MR - D9
Musculoskeletal Aging: where East meets West
Chairperson: Elaine Dennison
Chairperson: Elaine Dennison
08:00
MR - D9
Musculoskeletal aging in the oldest old: when East meets West
08:00
MR - D9
The ROAD study: an overview
08:00
MR - D9
The SALSA study: an overview
08:00
MR - D9
How does musculoskeletal health and its determinants in East and West differ?
08:00
MR - D8
Cardiovascular Comorbidities in Osteoporosis: WHO Report
Chairperson: Peter Ebeling
Chairperson: Peter Ebeling
08:00
MR - D8
Move to Improve: Osteoporosis, Cardiovascular Risk, and the Role of Exercise in Healthy Aging
08:00
MR - D8
Bone Appétit: Influence of Cardiovascular Disease on Musculoskeletal Health: A Key Role for Nutrition?
08:00
MR - D8
A Model of Atherosclerotic Calcifications as a Consequence of Osteoporosis
08:00
MR - D8
Q&A
08:00
MR - D3
The metabolic profile of psoriatic disease. Obesity, musculoskeletal manifestations and management
Chairperson: Panagiotis Athanassiou
Chairperson: Panagiotis Athanassiou
08:00
MR - D3
Psoriatic disease
08:00
MR - D3
Psoriatic disease and metabolic syndrome
08:00
MR - D3
Psoriatic disease and obesity
08:00
MR - D3
Psoriatic disease and treatment
08:00
MR- D4
Standardizing Periprosthetic DXA in Hip and Knee Arthroplasty: From Variability to Robust Data
Chairpersons: Jose Francisco Torres-Naranjo, Cristina Ojeda-Thies
Chairpersons: Jose Francisco Torres-Naranjo, Cristina Ojeda-Thies
08:00
MR- D4
Why Periprosthetic DXA Needs Standardization: Evidence, Variability, and the RAND/UCLA Process
08:00
MR- D4
From Pixels to Protocols: A Practical Framework for High-Quality Periprosthetic DXA
08:00
MR- D4
Interpreting Perprosthetic BMD: Precision, Longitudinal Change, and Therapy-Aware Flags
08:00
MR - D1
Capture the Fracture® - Building High-Quality Fracture Liaison Services: Practical Lessons from Global Experience
Chairperson: Maria Luisa Brandi
Chairperson: Maria Luisa Brandi
08:00
MR - D1
The FLS history in Italy: A decade of action
08:00
MR - D1
Learning from peers and building a strong FLS community – the Japanese experience
08:00
MR - D1
A set of variables for the assessment of Fragility Fracture patients in an FLS environment in Latin America (Country Specific Datasets)
08:00
MR - D1
Q&A
08:00
MR - D2
Effects of mineral waters on muscle and bone
Chairpersons: Giovanni Iolascon, Silvia Migliaccio
Chairpersons: Giovanni Iolascon, Silvia Migliaccio
08:00
MR - D2
Nutritional determinants of Musculoskeletal Health
08:00
MR - D2
Mineral Waters and the Musculoskeletal System
08:00
MR - D2
The Role of Mineral-Rich Waters in Managing Musculoskeletal Fragility: preliminary data from the FOCUS study
08:00
MR - D2
Discussion
08:00 - 09:00
MR - C1
ESCEO-DVO Joint Symposium: Current highlights in Osteology
Chairpersons: Ralf Schmidmaier, Manju Chandran
Chairpersons: Ralf Schmidmaier, Manju Chandran
08:00
MR - C1
One for all? Scoring of vertebral fractures?
08:20
MR - C1
Treatment induced osteoporosis in women with breast cancer - the updated position statement
08:40
MR - C1
Fracture and Osteoporosis - Riskfactor, Endpoint, Complication,Treatment
08:00 - 09:00
MR - D12
ESCEO Symposium: Update of the 2017 recommendations for the use of Hyaluronic Acid injections in patients with knee osteoarthritis: a patient-centered experts’ consensus
Chairpersons: François Rannou, Ali Mobasheri
Chairpersons: François Rannou, Ali Mobasheri
08:00
MR - D12
Efficacy of IAHA in osteoarthritis
08:00
MR - D12
Safety of IAHA in osteoarthritis
08:00
MR - D12
New perspectives in the use of IAHA for the management of osteoarthritis
08:00
MR - D12
Discussion leaders
09:00 - 10:30
Auditorium 1
Scientific Session I
Chairpersons: Charlotte Beaudart, Peter Ebeling
Chairpersons: Charlotte Beaudart, Peter Ebeling
09:00
Auditorium 1
Plenary Lecture
Management of very high fracture risk in the context of a lifelong osteoporosis treatment plan
Management of very high fracture risk in the context of a lifelong osteoporosis treatment plan
09:30
Auditorium 1
Oral communications selected from abstracts
OC1 - PREDICTIVE VALUE OF BMD FOR HIP AND OTHER FRACTURES: A META-ANALYSIS TO UPDATE FRAX
OC1 - PREDICTIVE VALUE OF BMD FOR HIP AND OTHER FRACTURES: A META-ANALYSIS TO UPDATE FRAX
09:40
Auditorium 1
Oral communications selected from abstracts
OC2 - LIFE EXPECTANCY FOLLOWING FIRST DXA - ARE MEN REFERRED TOO LATE? AN ANALYSIS OF THE 1900-1960 BIRTH COHORT
OC2 - LIFE EXPECTANCY FOLLOWING FIRST DXA - ARE MEN REFERRED TOO LATE? AN ANALYSIS OF THE 1900-1960 BIRTH COHORT
09:50
Auditorium 1
Oral communications selected from abstracts
OC3 - EARLY INITIATION OF OSTEOPOROSIS TREATMENT AFTER FRACTURE REDUCES SECONDARY FRACTURES IN ADULTS AGED ≥75 YEARS
OC3 - EARLY INITIATION OF OSTEOPOROSIS TREATMENT AFTER FRACTURE REDUCES SECONDARY FRACTURES IN ADULTS AGED ≥75 YEARS
10:00
Auditorium 1
Oral communications selected from abstracts
OC4 - TIMING OF ANTI-OSTEOPOROTIC TREATMENT INITIATION AFTER VERTEBRAL FRACTURE AND RISK OF NEW FRACTURE IN A FLS MODEL
OC4 - TIMING OF ANTI-OSTEOPOROTIC TREATMENT INITIATION AFTER VERTEBRAL FRACTURE AND RISK OF NEW FRACTURE IN A FLS MODEL
10:10
Auditorium 1
Oral communications selected from abstracts
OC5 - THE NUMBER NEEDED TO TREAT (NNT) ANALYSIS: A CLINICAL CONTEXT FOR THE TREATMENT-RELATED CHANGE IN TOTAL HIP BONE MINERAL DENSITY: THE ASBMR-SABRE PROJECT
OC5 - THE NUMBER NEEDED TO TREAT (NNT) ANALYSIS: A CLINICAL CONTEXT FOR THE TREATMENT-RELATED CHANGE IN TOTAL HIP BONE MINERAL DENSITY: THE ASBMR-SABRE PROJECT
10:20
Auditorium 1
Oral communications selected from abstracts
OC6 - ADHERENCE TO CARDIOVASCULAR RISK MINIMIZATION MEASURES FOR ROMOSOZUMAB: INTERIM RESULTS FROM A EUROPEAN MULTI-DATABASE DRUG UTILISATION STUDY
OC6 - ADHERENCE TO CARDIOVASCULAR RISK MINIMIZATION MEASURES FOR ROMOSOZUMAB: INTERIM RESULTS FROM A EUROPEAN MULTI-DATABASE DRUG UTILISATION STUDY
10:30 - 12:15
Auditorium 1
Scientific Session II
Chairpersons: Radmila Matijevic, Etienne Cavalier
Chairpersons: Radmila Matijevic, Etienne Cavalier
10:30
Auditorium 1
Presentation of the 2026 ESCEO Medal of Excellence
10:40
Auditorium 1
Plenary Lecture
Barriers and facilitators for orthogeriatric success
Barriers and facilitators for orthogeriatric success
11:10
Auditorium 1
Oral communications selected from abstracts
OC7 - REVISED SWEDISH FRAX MODELS AND THE ESTABLISHMENT OF AGE-DEPENDENT INTERVENTION THRESHOLDS
OC7 - REVISED SWEDISH FRAX MODELS AND THE ESTABLISHMENT OF AGE-DEPENDENT INTERVENTION THRESHOLDS
11:20
Auditorium 1
Oral communications selected from abstracts
OC8 - IMPROVED 10-YEAR FRACTURE RISK PREDICTION WITH THE “;BONE STRAIN INDEX“; BEYOND BONE MINERAL DENSITY AND FRAX® IN COMMUNITY-DWELLING OLDER WOMEN
OC8 - IMPROVED 10-YEAR FRACTURE RISK PREDICTION WITH THE “;BONE STRAIN INDEX“; BEYOND BONE MINERAL DENSITY AND FRAX® IN COMMUNITY-DWELLING OLDER WOMEN
11:30
Auditorium 1
Oral communications selected from abstracts
OC9 - EROSIVE HAND OSTEOARTHRITIS IS ASSOCIATED WITH INCREASED RISK OF INCIDENT OSTEOPOROTIC FRACTURES IN POST-MENOPAUSAL WOMEN (QUALYOR COHORT)
OC9 - EROSIVE HAND OSTEOARTHRITIS IS ASSOCIATED WITH INCREASED RISK OF INCIDENT OSTEOPOROTIC FRACTURES IN POST-MENOPAUSAL WOMEN (QUALYOR COHORT)
11:40
Auditorium 1
Oral communications selected from abstracts
OC10 - MUSCULOSKELETAL HEALTH AND LIFE-SPACE MOBILITY, SOCIAL ISOLATION AND LONELINESS IN THE OLDEST OLD: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY
OC10 - MUSCULOSKELETAL HEALTH AND LIFE-SPACE MOBILITY, SOCIAL ISOLATION AND LONELINESS IN THE OLDEST OLD: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY
11:50
Auditorium 1
Oral communications selected from abstracts
OC11 - BONE COMPONENT DISORGANIZATION IN METABOLIC AND GENETIC BONE DISEASES, INCLUDING HYPOPHOSPHATASIA: NOVEL INSIGHTS INTO DISEASE PATHOGENESIS AND PATIENT ASSESSMENT
OC11 - BONE COMPONENT DISORGANIZATION IN METABOLIC AND GENETIC BONE DISEASES, INCLUDING HYPOPHOSPHATASIA: NOVEL INSIGHTS INTO DISEASE PATHOGENESIS AND PATIENT ASSESSMENT
12:00
Auditorium 1
Oral communications selected from abstracts
OC12 - BONE COMPONENT DISORGANIZATION IN METABOLIC AND GENETIC BONE DISEASES, INCLUDING HYPOPHOSPHATASIA: NOVEL INSIGHTS INTO DISEASE PATHOGENESIS AND PATIENT ASSESSMENT
OC12 - BONE COMPONENT DISORGANIZATION IN METABOLIC AND GENETIC BONE DISEASES, INCLUDING HYPOPHOSPHATASIA: NOVEL INSIGHTS INTO DISEASE PATHOGENESIS AND PATIENT ASSESSMENT
12:15 - 13:45
Auditorium 1
Sponsored Lunch Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
12:15 - 13:45
Auditorium 2
Sponsored Lunch Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
14:00 - 15:00
Meet-The-Expert Session
14:00
MR - D9
PTH, vitamin D and bone turnover markers from the laboratory perspective: more than you can eat!
14:00
MR - D8
Skeletal microarchitecture and fracture risk
14:00
MR - D1
FLS: current global challenges
14:00
MR - D2
Managing bone health after bariatric surgery
14:00 - 15:00
MR- D4
Revolution in Osteoporosis Patient Care – Necessity, Opportunities, Possibilities and Results. The Czech Paradigm
Chairpersons: Eugene McCloskey, Vladimir Palicka, Richard Pikner
Chairpersons: Eugene McCloskey, Vladimir Palicka, Richard Pikner
14:00
MR- D4
Osteoporosis Care in the Czech Republic: where we are and where we go
14:20
MR- D4
Czech National Population Programme for Early Detection of Osteoporosis - Methodology, Principles, and 30 Months Results
14:45
MR- D4
Discussion
14:00 - 15:00
Podium
Oral presentations of selected posters
Chairperson: Elaine Dennison
Chairperson: Elaine Dennison
14:00
Podium
OP1 - P416 - FROM WRIST TO HIP: CAN EARLY FLS INTERVENTION AFTER A DISTAL RADIUS FRACTURE PREVENT THE NEXT FRAGILITY FRACTURE
14:06
Podium
OP2 - P1154 - ASSOCIATION BETWEEN THE TREATMENT-RELATED CHANGE IN BONE MINERAL DENSITY AND FRACTURE RISK REDUCTION ACCORDING TO THE PRE-TREATMENT BMD: ANALYSIS FROM THE FNIH-ASBMR SABRE PROJECT
14:12
Podium
OP3 - P1770 - REAL-WORLD TREATMENT STRATEGIES FOR OSTEOPOROSIS IN OLDER ADULTS WITH CKD-MBD: IMPACT OF GERIATRIC SYNDROMES AND TREATMENT COMPLIANCE
14:18
Podium
OP4 - P365 - GLP-1 RECEPTOR AGONISTS AND MUSCULOSKELETAL OUTCOMES: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
14:24
Podium
OP5 - P1076 - BISPHOSPHONATES OR DENOSUMAB AFTER FRACTURE? REAL-WORLD EVIDENCE FROM A TARGET TRIAL EMULATION IN MULTIMORBID ADULTS
14:36
Podium
OP7 - P806 - HIP BONE COMPARTMENT RESPONSES TO ROMOSOZUMAB VERSUS ALENDRONATE IN PATIENTS WITH DIABETES: A SUBGROUP ANALYSIS FROM THE ARCH TRIAL USING 3D-DXA MODELLING
14:42
Podium
OP8 - P261 - THE EFFECTIVENESS OF THE INTENSIVE CARE PROGRAM FOR FLS IMPLEMENTATION TO REDUCE MORPHOMETRIC VERTEBRAL FRACTURES IN OSTEOPOROSIS PATIENTS AT VERY HIGH FRACTURE RISK COMPARED TO THE PRIMARY CARE PHYSICIAN-LED STANDARD CARE: JOINT-08 TRIAL
14:48
Podium
OP9 - P1011 - BONE HEALTH IN PATIENTS WITH NON-METASTATIC PROSTATE CANCER ON ANDROGEN DEPRIVATION THERAPY INTERNATIONAL OSTEOPOROSIS FOUNDATION – BONE AND CANCER WORKING GROUP – POSITION STATEMENT
14:54
Podium
OP10 - P427 - OSTEOPOROSIS AND HEARING LOSS: NATIONWIDE EVIDENCE FOR AN EXTRA-SKELETAL PROTECTIVE EFFECT OF ZOLEDRONIC ACID AND DENOSUMAB
15:00
Podium
OP11 - P739 - TRANSLATING MOLECULAR INSIGHTS INTO CLINICAL PROGRESS: RJX-01 FOR MUSCLE RECOVERY AND OSTEOSARCOPENIA THERAPY
14:00 - 15:00
MR - C1
ESCEO Symposium: GLP-1 Receptor Agonists and Musculoskeletal Health
Chairpersons: René Rizzoli, Nicholas Harvey
Chairpersons: René Rizzoli, Nicholas Harvey
14:00
MR - C1
Introduction
14:05
MR - C1
GLP1 Receptor Agonists and bone health
14:20
MR - C1
GLP1 Receptor Agonists and joint health
14:35
MR - C1
GLP1 Receptor Agonists and muscle health
14:50
MR - C1
Discussion and conclusion
14:00 - 15:00
MR - D12
ESCEO Symposium: New perspectives on clinical and regulatory aspects of sarcopenia management
Chairpersons: Nicholas Fuggle, Andrea Laslop
Chairpersons: Nicholas Fuggle, Andrea Laslop
14:00
MR - D12
Introduction
14:05
MR - D12
Sarcopenia: state of the art in disease definition and clinical translation
14:20
MR - D12
Development of novel muscle-active agents: a regulatory perspective
14:35
MR - D12
Discussion
15:00 - 16:45
MR - D12
Committee of National Societies Special Plenary Session: From Research to Clinical Practice: Bridging the Gap in Bone Health
Chairperson: Famida Jiwa
Chairperson: Famida Jiwa
15:18
MR - D12
OCs2 - REIMAGINING ROUTINE HEALTH INFORMATION SYSTEMS TO DETECT FRACTURE RISK AND OSTEOPOROSIS: A POLICY BRIEF PREPARED FOR THE WORLD HEALTH ORGANISATION (WHO)
15:26
MR - D12
OCs3 - MULTI-CENTER VALIDATION OF A FEDERATED LEARNING-BASED ARTIFICIAL INTELLIGENCE SYSTEM FOR SCREENING LOW BONE MINERAL DENSITY USING CHEST X-RAYS
15:34
MR - D12
OCs4 - GLP-1 RECEPTOR AGONISTS AND MUSCULOSKELETAL OUTCOMES: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
15:42
MR - D12
OCs5 - FRAGILITY RUNS IN THE FAMILY: INTERGENERATIONAL CLUSTERING OF OSTEOPOROSIS IN A RURAL INDIAN COHORT
15:50
MR - D12
Presentation of the IOF Committee of National Societies Medal
16:00
MR - D12
OCs6 - DEVELOPMENT AND VALIDATION OF DIABETES HIP FRACTURE SCORE (D-HFS) IN PATIENTS WITH TYPE 2 DIABETES: A POPULATION-BASED COHORT STUDY OF HONG KONG
16:08
MR - D12
OCs7 - LIFESTYLE AND CLINICAL FACTORS ASSOCIATED WITH FEMORAL NECK BONE MINERAL DENSITY IN AFRICAN ADULTS: FINDINGS FROM THE FRACTURE-E3 STUDY
16:16
MR - D12
OCs8 - USING RESEARCH TO TRANSFORM HEALTH POLICY FOR PATIENTS WITH FRAGILITY FRACTURE IN BRITISH COLUMBIA, CANADA
16:32
MR - D12
OCs10 - AI-ASSISTED OPPORTUNISTIC DETECTION OF VERTEBRAL COMPRESSION FRACTURES IN CT SCANS
15:00 - 17:00
Auditorium 1
Scientific Session III
Chairpersons: Richard Pikner, Patricia Clark
Chairpersons: Richard Pikner, Patricia Clark
15:00
Auditorium 1
Plenary Lecture
Hyperglycaemia and bone health: disease and therapy
Hyperglycaemia and bone health: disease and therapy
15:30
Auditorium 1
Oral communications selected from abstracts
OC13 - INCIDENCE OF NEW OSTEOPOROTIC FRACTURES UP TO THREE YEARS OF FOLLOW-UP IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS WHO INITIATE ANY OSTEOPOROSIS MEDICATION COMPARED TO NON-DIABETICS: A POPULATION-BASED COHORT STUDY
OC13 - INCIDENCE OF NEW OSTEOPOROTIC FRACTURES UP TO THREE YEARS OF FOLLOW-UP IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS WHO INITIATE ANY OSTEOPOROSIS MEDICATION COMPARED TO NON-DIABETICS: A POPULATION-BASED COHORT STUDY
15:40
Auditorium 1
Oral communications selected from abstracts
OC14 - TYPE 2 DIABETES MELLITUS AND FRACTURE RISK: AN INTERNATIONAL META-ANALYSIS
OC14 - TYPE 2 DIABETES MELLITUS AND FRACTURE RISK: AN INTERNATIONAL META-ANALYSIS
15:50
Auditorium 1
Oral communications selected from abstracts
OC15 - LONGITUDINAL EFFECTS OF DENOSUMAB, ROMOSOZUMAB, AND COMBINATION THERAPY ON MUSCLE QUALITY AND METABOLIC PROFILES A RANDOMIZED CONTROLLED TRIAL
OC15 - LONGITUDINAL EFFECTS OF DENOSUMAB, ROMOSOZUMAB, AND COMBINATION THERAPY ON MUSCLE QUALITY AND METABOLIC PROFILES A RANDOMIZED CONTROLLED TRIAL
16:00
Auditorium 1
Oral communications selected from abstracts
OC16 - PREGNANCY-RELATED CHANGES IN BONE HEALTH: A LONGITUDINAL REMS-BASED STUDY
OC16 - PREGNANCY-RELATED CHANGES IN BONE HEALTH: A LONGITUDINAL REMS-BASED STUDY
16:10
Auditorium 1
Oral communications selected from abstracts
OC17 - COST-EFFECTIVENESS OF AI-ENHANCED OPPORTUNISTIC OSTEOPOROSIS SCREENING USING CHEST RADIOGRAPHS: EVIDENCE FROM SIX INTERNATIONAL ANALYSES
OC17 - COST-EFFECTIVENESS OF AI-ENHANCED OPPORTUNISTIC OSTEOPOROSIS SCREENING USING CHEST RADIOGRAPHS: EVIDENCE FROM SIX INTERNATIONAL ANALYSES
16:20
Auditorium 1
Oral communications selected from abstracts
OC18 - CLINICALLY INTERPRETABLE PREDICTORS OF IMMINENT SUBSEQUENT FRACTURES IN A DEEP-LEARNING PREDICTION MODEL
OC18 - CLINICALLY INTERPRETABLE PREDICTORS OF IMMINENT SUBSEQUENT FRACTURES IN A DEEP-LEARNING PREDICTION MODEL
16:30
Auditorium 1
Plenary Lecture
Is there a role for sex hormones in the management of musculoskeletal disorders?
Is there a role for sex hormones in the management of musculoskeletal disorders?
17:00 - 18:30
Auditorium 1
Sponsored Satellite Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
17:00 - 18:30
Auditorium 2
Available Sponsored Satellite Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
18:30 - 19:30
Non-Sponsored Symposia
18:30
MR - C1
Bone Turnover Markers in CKD-Associated Osteoporosis: Translating European Consensus to Practice
Chairpersons: Maria Fusaro, Etienne Cavalier
Chairpersons: Maria Fusaro, Etienne Cavalier
18:30
MR - C1
Applying Bone Turnover Markers in Dialysis and Transplantation: Case-Based Insights
18:30
MR - C1
BALP, TRACP-5b and iPINP: New Reference Markers and Diagnostic Cut-offs in CKD
18:30
MR - D9
Clinical Outcomes of Sarcopenia: A GLIS Symposium
Chairpersons: Alfonso Cruz Jentoft, Jean-Yves Reginster
Chairpersons: Alfonso Cruz Jentoft, Jean-Yves Reginster
18:30
MR - D9
The Global Leadership Initiative on Sarcopenia (GLIS): objectives, structure, and achievements
18:30
MR - D9
Health outcomes of sarcopenia: Insights from the GLIS Outcome Working Group and clinical implications
18:30
MR - D9
Updated meta-analysis on the health outcomes of sarcopenia
18:30
MR - D12
Mind Body Exercises: Yoga and its effect on Bone and Muscle Health: Myth, Magic, or Measurable Impact?
Chairperson: Ambrish Mithal
Chairperson: Ambrish Mithal
18:30
MR - D12
Introduction to Yoga and Its Relevance to Musculoskeletal Health
18:30
MR - D12
Effect of Yoga on bone mineral metabolism
18:30
MR - D12
Effect of yoga on muscle strength
18:30
MR - D12
Yoga demonstration
18:30
MR - D12
Q&A
18:30
MR - D2
Women’s Bone Health and Hormones Therapy Update: Integrating Gynecology Into Multidisciplinary Osteoporosis Care
Chairpersons: Maria Celeste Osório Wender, Adriana Orcesi Pedro
Chairpersons: Maria Celeste Osório Wender, Adriana Orcesi Pedro
18:30
MR - D2
Estradiol Therapy in 2026: Optimizing Type, Dose, and Route for Bone Protection Across Menopausal Stages.
18:30
MR - D2
Beyond Endometrial Safety: Do Different Progestogens Change Long-Term Skeletal and Metabolic Risk?
18:30
MR - D2
Androgens and the Female Musculoskeletal System: Evidence, Gaps, and the Future of Therapy.
18:30
MR - D2
Q&A
18:30
MR - D3
Osteoporosis in Inflammatory Diseases: Clinical Challenges and Diagnostic Gaps
Chairperson: Elena Bischoff
Chairperson: Elena Bischoff
18:30
MR - D3
High prevalence of osteoporosis in autoimmune and inflammatory diseases
18:30
MR - D3
Clinical Challenges and Diagnostic Gaps: REMS technology
18:30
MR- D4
Managing Bone Fragility in Older Adults with Diabetes: Pathophysiology, Assessment, and Therapeutic Considerations in Older Adults
Chairpersons: Gulistan Bahat, Dilek Gogas Yavuz
Chairpersons: Gulistan Bahat, Dilek Gogas Yavuz
18:30
MR- D4
Pathophysiology, Risk Assessment Challenges, and Non-Pharmacological Strategies in Diabetic Bone Fragility
18:30
MR- D4
Skeletal Effects of Anti-Diabetic Drugs and Osteoporosis Management in Patients with Diabetes
18:30
MR - D1
Artificial Intelligence in Osteoporosis: What's new and what's next
Chairperson: Nicholas Fuggle
Chairperson: Nicholas Fuggle
18:30
MR - D1
The Al Landscape in Bone Health 2026: From Multimodal Models to Clinical Agents
18:30
MR - D1
Current ML models for predicting fracture risk - Do they meet the clinical need and if not then what are the next steps?
18:30
MR - D1
Ensuring Safe, Equitable, and Regulated Al in Osteoporosis Care
18:30
MR - D7
Kidney and bone health in hypoparathyroidism
Chairperson: Maria Luisa Brandi
Chairperson: Maria Luisa Brandi
18:30
MR - D7
Kidney health in hypoparathyroidism
18:30
MR - D7
Bone health in hypoparathyroidism
18:30
MR - D8
Hip Fracture and Osteoporosis
Chairperson: Christopher Niedhart
Chairperson: Christopher Niedhart
18:30
MR - D8
Hip Biomechanics and Fracture Risk: Beyond Bone Density
18:30
MR - D8
Management of Hip Fractures – The German Approach
18:30
MR - D8
Local Bone Augmentation to Prevent Hip Fractures
Saturday April 18th - CEST Timezone
08:00 - 09:00
Non-Sponsored Symposia
08:00
MR - D9
Update in Musculoskeletal Conditions with Hand Involvement
Chairpersons: Fitnat Dincer, Andreas Winkelmann
Chairpersons: Fitnat Dincer, Andreas Winkelmann
08:00
MR - D9
Update in Degenerative joint disease of Hand, Osteoarthritic Hand
08:00
MR - D9
Update in Soft tissue lesions /non articular involvement of Hand
08:00
MR - D8
Music, Rhythm, Music, and Cognition: Implementing Dalcroze Eurhythmics to Preserve Capacity in Care Home Residents
Chairpersons: Yasser El Miedany, Naglaa Gadallah
Chairpersons: Yasser El Miedany, Naglaa Gadallah
08:00
MR - D8
The Neurological Symphony: Rhythmic Auditory-Motor Coupling and Dual-Task Training Effects of Eurhythmics on Balance and Executive Function
08:00
MR - D8
"The Moving Body": Developing a Scalable and Safe Dalcroze Protocol for Older Adults with Varying Cognitive and Physical Limitations in Residential Care
08:00
MR - D8
Beyond Falls: Assessing the Impact of Dalcroze Eurhythmics on Quality of Life, Social Engagement, and Care Home Service Cost-Effectiveness
08:00
MR - D1
Muscle impairment in patients with rheumatic diseases: A pragmatic approach
Chairpersons: Osvaldo Daniel Messina, Jorge Luis Alberto Morales-Torres
Chairpersons: Osvaldo Daniel Messina, Jorge Luis Alberto Morales-Torres
08:00
MR - D1
Introduction: the need for pragmatic approaches for patients at risk.
08:00
MR - D1
Muscle impairment: the problem with outcomes
08:00
MR - D1
Muscle impairment: adapting diagnosis to joint limitations
08:00
MR - D1
Muscle impairment: primary and secondary prevention today
08:00
MR - D1
Discussion and conclusions
08:00
MR - D2
Multimorbidity and Fracture Outcomes
Chairpersons: Jacqueline R. Center, Robert D. Blank
Chairpersons: Jacqueline R. Center, Robert D. Blank
08:00
MR - D2
Multimorbidity contribues to the osteoporosis treatment gap.
08:00
MR - D2
Multimorbidity double burden: Elevated fracture risk despite high mortality following fracture.
08:00
MR - D2
Risk stratification for imminent subsequent fractures: A DeepHit approach using administrative health data.
08:00
MR- D4
Low-dose Radiotherapy in Musculoskeletal Disorders: Emerging Strategies for Pain Management and Inflammatory Modulation
Chairperson: África Fernández Forné
Chairperson: África Fernández Forné
08:00
MR- D4
Low-dose radiotherapy in degenerative musculoskeletal disorders: From radiobiological principles to clinical practice.
08:00
MR- D4
Beyond conventional therapies: A rheumatologist’s perspective on the management of complex and refractory patients.
08:00
MR- D4
Building clinical evidence: Preliminary results from the FINGERT and TROCANTERT studies
08:00
MR- D4
Discussion and Q&A
08:00
MR - D7
Emphasizing the importance of osteoporotic vertebral fractures: focus on diagnosis and care.
Chairperson: Anabela Barcelos
Chairperson: Anabela Barcelos
08:00
MR - D7
Early Detection of Vertebral Fragility Fractures: Bridging the Diagnostic Gap
08:00
MR - D7
Opportunistic diagnosis of vertebral fractures using routine CT-scans: the Portuguese experience and literature review
08:00
MR - D7
Assessing Quality of Life After Vertebral Fracture: The Value of the Portuguese-Validated QUALEFFO-41 Over Generic Instruments
08:00
MR - D7
Closing remarks
08:00 - 09:00
Auditorium 1
Sponsored Satellite Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
08:00 - 09:00
Auditorium 2
Sponsored Breakfast Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
08:00 - 09:00
MR - D12
WFS-IOF-ESCEO Joint Symposium:Fracture Prevention in Older Adults
Chairpersons: Tahir Masud, Nicholas Harvey
Chairpersons: Tahir Masud, Nicholas Harvey
08:00
MR - D12
Pharmacological treatments for osteoporosis in the oldest older persons
08:20
MR - D12
The interplay between osteoporosis, dementia and fragility fractures
08:40
MR - D12
Reducing falls and fractures by medication optimisation
09:00 - 10:30
Auditorium 1
Scientific Session IV
Chairpersons: Fitnat Dincer, Vladimir Palicka
Chairpersons: Fitnat Dincer, Vladimir Palicka
09:00
Auditorium 1
Plenary Lecture
En route to a global sarcopenia consensus
En route to a global sarcopenia consensus
09:30
Auditorium 1
Oral communications selected from abstracts
OC19 - HIGH MORTALITY IN OLDER MEN WITH LOW MUSCLE MASS AND STRENGTH – THE PROSPECTIVE STRAMBO STUDY
OC19 - HIGH MORTALITY IN OLDER MEN WITH LOW MUSCLE MASS AND STRENGTH – THE PROSPECTIVE STRAMBO STUDY
09:40
Auditorium 1
Oral communications selected from abstracts
OC20 - LOWER INTRINSIC CAPACITY AND SARCOPENIA: DATA FROM THE GEELONG OSTEOPOROSIS STUDY
OC20 - LOWER INTRINSIC CAPACITY AND SARCOPENIA: DATA FROM THE GEELONG OSTEOPOROSIS STUDY
09:50
Auditorium 1
Oral communications selected from abstracts
OC21 - INCREASED DIETARY FIBER INTAKE IS ASSOCIATED WITH BETTER GRIP STRENGTH AND PHYSICAL PERFORMANCE IN COMMUNITY-DWELLING OLDER ADULTS
OC21 - INCREASED DIETARY FIBER INTAKE IS ASSOCIATED WITH BETTER GRIP STRENGTH AND PHYSICAL PERFORMANCE IN COMMUNITY-DWELLING OLDER ADULTS
10:00
Auditorium 1
Oral communications selected from abstracts
OC22 - EFFECT OF DALCROZE EURHYTHMICS EXERCISE ON MUSCLE, PHYSICAL AND COGNITIVE FUNCTION, AND FALLS IN SARCOPENIC OLDER ADULTS: THE SARCARE RANDOMIZED CONTROLLED TRIAL
OC22 - EFFECT OF DALCROZE EURHYTHMICS EXERCISE ON MUSCLE, PHYSICAL AND COGNITIVE FUNCTION, AND FALLS IN SARCOPENIC OLDER ADULTS: THE SARCARE RANDOMIZED CONTROLLED TRIAL
10:10
Auditorium 1
Oral communications selected from abstracts
OC23 - IDENTIFICATION OF FACTORS ASSOCIATED WITH NON-RESPONSE TO A MULTICOMPONENT INTERVENTION IN OLDER ADULTS WITH PHYSICAL FRAILTY AND SARCOPENIA
OC23 - IDENTIFICATION OF FACTORS ASSOCIATED WITH NON-RESPONSE TO A MULTICOMPONENT INTERVENTION IN OLDER ADULTS WITH PHYSICAL FRAILTY AND SARCOPENIA
10:20
Auditorium 1
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award
10:30 - 12:15
Auditorium 1
Scientific Session V
Chairpersons: Manju Chandran, Karel Pavelka
Chairpersons: Manju Chandran, Karel Pavelka
10:30
Auditorium 1
Presentation of the IOF Olof Johnell Science Award
10:35
Auditorium 1
Presentation of the ESCEO-IOF Young Investigator Awards
10:40
Auditorium 1
Presentation of the ESCEO-Aging Clinical and Experimental Research Award
10:45
Auditorium 1
Plenary Lecture
Nutritional strategies for optimal muscle health
Nutritional strategies for optimal muscle health
11:15
Auditorium 1
Oral communications selected from abstracts
OC24 - CAN AI-DERIVED BMD FROM ROUTINE RADIOGRAPHS PREDICT FRACTURE RISK? A 6-YEAR FOLLOW-UP STUDY
OC24 - CAN AI-DERIVED BMD FROM ROUTINE RADIOGRAPHS PREDICT FRACTURE RISK? A 6-YEAR FOLLOW-UP STUDY
11:25
Auditorium 1
Oral communications selected from abstracts
OC25 - FOREARM BMD IS A FRAX INDEPENDENT PREDICTOR OF FRACTURE RISK
OC25 - FOREARM BMD IS A FRAX INDEPENDENT PREDICTOR OF FRACTURE RISK
11:35
Auditorium 1
Oral communications selected from abstracts
OC26 - PREDICTION OF INCIDENT FRACTURES USING THE AI-BASED TBS REVEAL BONE FRAGILITY INDEX: A BAYESIAN SURVIVAL ANALYSIS
OC26 - PREDICTION OF INCIDENT FRACTURES USING THE AI-BASED TBS REVEAL BONE FRAGILITY INDEX: A BAYESIAN SURVIVAL ANALYSIS
11:45
Auditorium 1
Oral communications selected from abstracts
OC27 - 3D-SHAPER DIFFERENTIATION OF CORTICAL AND TRABECULAR BONE DESCRIBES FRACTURE STATUS IN PATIENTS WITH KIDNEY DISEASE
OC27 - 3D-SHAPER DIFFERENTIATION OF CORTICAL AND TRABECULAR BONE DESCRIBES FRACTURE STATUS IN PATIENTS WITH KIDNEY DISEASE
11:55
Auditorium 1
Oral communications selected from abstracts
OC28 - PERFORMANCE OF NOGG GUIDELINES BASED ON FRAX PRIOR TO DXA VS FRAX CALCULATED USING A FEMORAL NECK ESTIMATE FROM AN OPPORTUNISTIC SCREEN OF LOW BONE DENSITY FROM STANDARD X-RAY
OC28 - PERFORMANCE OF NOGG GUIDELINES BASED ON FRAX PRIOR TO DXA VS FRAX CALCULATED USING A FEMORAL NECK ESTIMATE FROM AN OPPORTUNISTIC SCREEN OF LOW BONE DENSITY FROM STANDARD X-RAY
12:05
Auditorium 1
Oral communications selected from abstracts
OC29 - SUPERIOR FRAGILITY FRACTURE DISCRIMINATION BY CORTICAL ULTRASOUND SPECTROSCOPY COMPARED WITH BONE MINERAL DENSITY IN WOMEN AND MEN
OC29 - SUPERIOR FRAGILITY FRACTURE DISCRIMINATION BY CORTICAL ULTRASOUND SPECTROSCOPY COMPARED WITH BONE MINERAL DENSITY IN WOMEN AND MEN
12:15 - 13:45
Auditorium 1
Sponsored Satellite Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
12:15 - 13:45
Auditorium 2
Sponsored Satellite Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
14:00 - 15:00
Meet-The-Expert Session
14:00
MR - D9
Screening for high fracture risk
14:00
MR - D8
Rare bone diseases for the osteoporosis physician
14:00
MR - D1
Meta-analysis: makings sense of umbrella and network approaches
14:00
MR - D2
Exercise: what to recommend in osteoporosis
14:00 - 15:00
Podium
Oral presentations of selected posters
Chairperson: Elaine Dennison
Chairperson: Elaine Dennison
14:00
Podium
OP12 - P1094 - WHAT PROPORTION OF WOMEN EXPERIENCE SIGNIFICANT TRANSMENOPAUSAL BONE LOSS?
14:06
Podium
OP13 - P1496 - APPLICATION OF MACHINE LEARNING MODELS FOR OSTEOPOROSIS SCREENING: BUSHEHR ELDERLY HEALTH (BEH) PROGRAM
14:12
Podium
OP14 - P1702 - HOW COMMON IS IT? HIGH AND VERY HIGH-RISK FRACTURE RATES AMONG PATIENTS WITH A NON-OSTEOPOROTIC-RANGE BONE MINERAL DENSITY IN A DXA DATABASE FROM A TERTIARY MEDICAL CENTER
14:18
Podium
OP15 - P807 - SERUM PER- AND POLYFLUOROALKYL SUBSTANCES (PFAS) AND BONE MINERAL DENSITY IN NORWEGIAN ADOLESCENTS: SEX-SPECIFIC ASSOCIATIONS AND MIXTURE EFFECTS
14:24
Podium
OP16 - P1370 - MATERNAL DIABETES IN PREGNANCY AND FRACTURE RISK IN OFFSPRING: A VICTORIA STATE-WIDE DATA LINKAGE STUDY
14:30
Podium
OP17 - P527 - SEX- AND DISTRIBUTION-SPECIFIC PROSPECTIVE MUSCLE-FAT-FRACTURE RELATIONSHIPS IN UK BIOBANK
14:36
Podium
OP18 - P735 - THE LANDSCAPE OF RENAL OSTEODYSTROPHY IN EUROPE: A FIRST REPORT FROM THE EUROD BONE BIOPSY DATABASE
14:42
Podium
OP19 - P1437 - LONG-TERM QUALITY OF LIFE TRAJECTORIES IN FIBROUS DYSPLASIA AND MCCUNE-ALBRIGHT SYNDROME
14:48
Podium
OP20 - P500 - IMPAIRED ORAL HEALTH PREDICTS FRACTURES AND FALLS IN OLDER ADULTS: A PROSPECTIVE COHORT STUDY
14:54
Podium
OP21 - P849 - THE SINTER STUDY: A RECALL-BY-GENOTYPE DESIGN WITH MULTIDIMENSIONAL MUSCULOSKELETAL PHENOTYPING ACROSS INTERNAL-MEDICINE OUTPATIENT CLINICS
15:00
Podium
OP22 - P586 - DEVELOPMENT AND EXPERT VALIDATION OF AN INTERNATIONAL POSTMENOPAUSAL OSTEOPOROSIS RISK ASSESSMENT AND LIFESTYLE (IPORL) QUESTIONNAIRE
15:06
Podium
OP23 - P386 - FRACTURES AND BONE MINERAL DENSITY LOSS IN ADULTS LIVING WITH HIV IN LOW- AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW AND META-ANALYSIS
14:00 - 15:00
MR- D4
Educational Lecture: CKD-Associated Osteoporosis: The Overlooked Burden of Bone Fragility in CKD
Chairperson: Maria Fusaro
Chairperson: Maria Fusaro
14:00
MR- D4
Denosumab use in advanced CKD patients: yes or no, this is the dilemma
14:00
MR- D4
Mendelian randomization role of vitamin D in coronary heart disease
14:00
MR- D4
Bone quality in CKD: How to assess and why it matters
14:00
MR- D4
KIDNEY-FRAX®: Is it the right time to perform it?
14:00 - 15:00
MR - D3
OARSI-ESCEO Symposium: Obesity and its implications for pain and structure in osteoarthritis
Chairpersons: Martin Englund, Jean-Yves Reginster
Chairpersons: Martin Englund, Jean-Yves Reginster
14:00
MR - D3
The role of obesity and adipose tissue dysfunction in osteoarthritis pain
14:00
MR - D3
Structural changes with weight loss in knee osteoarthritis
14:00 - 15:00
MR - D12
EuGMS-IOF-ESCEO Joint Symposium: Integrating falls and fractures management in the patient-centered care
Chairpersons: Nathalie Van der Velde, Carmelinda Ruggiero, René Rizzoli
Chairpersons: Nathalie Van der Velde, Carmelinda Ruggiero, René Rizzoli
14:00
MR - D12
Landscape for integrated falls and fragility fracture pathways across Europe: where do we stand?
14:00
MR - D12
Falls and fragility fractures in older adults with neurocognitive disorders: preparing for the impending storm
14:00
MR - D12
Integrating falls and fragility fractures secondary prevention: the small win of the orthogeriatric care pathway
15:00 - 16:45
MR - D12
Committee of Scientific Advisors Special Session:
Chairpersons: Eugene McCloskey, Etienne Cavalier
Chairpersons: Eugene McCloskey, Etienne Cavalier
15:00 - 17:00
Auditorium 1
Scientific Session VI
Chairpersons: Claudia Campusano, Atsushi Suzuki
Chairpersons: Claudia Campusano, Atsushi Suzuki
15:00
Auditorium 1
Plenary Lecture
State of the art: advances in osteoarthritis imaging
State of the art: advances in osteoarthritis imaging
15:30
Auditorium 1
Oral communications selected from abstracts
OC30 - INFRAPATELLAR FAT PAD MORPHOLOGY AND SIGNAL PREDICTS KNEE REPLACEMENT RISK IN OSTEOARTHRITIS: AN 8-YEAR MRI CASE-CONTROL STUDY
OC30 - INFRAPATELLAR FAT PAD MORPHOLOGY AND SIGNAL PREDICTS KNEE REPLACEMENT RISK IN OSTEOARTHRITIS: AN 8-YEAR MRI CASE-CONTROL STUDY
15:40
Auditorium 1
Oral communications selected from abstracts
OC31 - QUANTIFYING TREATMENT-RELATED INFLAMMATORY CHANGE IN KNEE OSTEOARTHRITIS USING NORMALIZED MRI INFLAMMATION VOLUME (NORMI)
OC31 - QUANTIFYING TREATMENT-RELATED INFLAMMATORY CHANGE IN KNEE OSTEOARTHRITIS USING NORMALIZED MRI INFLAMMATION VOLUME (NORMI)
15:50
Auditorium 1
Oral communications selected from abstracts
OC32 - FROM MODEL TO APPLICATION: METABOLOMIC-DRIVEN MACHINE LEARNING FOR PROGNOSIS OF KNEE STRUCTURAL OSTEOARTHRITIS PROGRESSION
OC32 - FROM MODEL TO APPLICATION: METABOLOMIC-DRIVEN MACHINE LEARNING FOR PROGNOSIS OF KNEE STRUCTURAL OSTEOARTHRITIS PROGRESSION
16:00
Auditorium 1
Oral communications selected from abstracts
OC33 - TOWARDS OA PATIENTS ENDOTYPING : DEVELOPMENT OF AN LC-MS/MS METHOD FOR THE QUANTITATION OF JOINT-RELATED COLLAGENS FRAGMENTS
OC33 - TOWARDS OA PATIENTS ENDOTYPING : DEVELOPMENT OF AN LC-MS/MS METHOD FOR THE QUANTITATION OF JOINT-RELATED COLLAGENS FRAGMENTS
16:10
Auditorium 1
Oral communications selected from abstracts
OC34 - Intra-articular polyacrylamide hydrogel for knee osteoarthritis: 1-year results from the LUNA observational study.
OC34 - Intra-articular polyacrylamide hydrogel for knee osteoarthritis: 1-year results from the LUNA observational study.
16:20
Auditorium 1
Oral communications selected from abstracts
OC35 - Expert consensus on hyaluronic acid injections for knee osteoarthritis: a patient-centered approach
OC35 - Expert consensus on hyaluronic acid injections for knee osteoarthritis: a patient-centered approach
16:30
Auditorium 1
Oral communications selected from abstracts
OC36 - IS EFFUSION SYNOVITIS, ASSESSED QUANTITATIVELY BY MORPHOMETRY OR SEMI-QUANTITATIVELY BY EXPERT READING; RELATED TO OSTEOARTHRITIS PROGRESSION
OC36 - IS EFFUSION SYNOVITIS, ASSESSED QUANTITATIVELY BY MORPHOMETRY OR SEMI-QUANTITATIVELY BY EXPERT READING; RELATED TO OSTEOARTHRITIS PROGRESSION
16:40
Auditorium 1
Plenary Lecture
Novel emerging therapies for osteoarthritis
Novel emerging therapies for osteoarthritis
17:10 - 18:10
Non-Sponsored Symposia
17:10
MR - C1
Narrowing the "Treatment Gap of Osteoporosis" Using the Optimal Clinical Paradigm
Chairperson: P. Dean Cummings
Chairperson: P. Dean Cummings
17:10
MR - C1
Closing the Care Gap: Defining a Scalable Pathway to Transform Bone Health Evaluation Across Health Systems
17:10
MR - C1
Integrating Biology, Behavior, Function, and Environment: A 4-Pillar Framework Driving Comprehensive Bone Health Optimization
17:10
MR - C1
Mapping the Future: Using Structured Assessment to Guide Implementation, Direction, and Impact in Bone Health Care
17:10
MR - D9
Vitamin D Metabolite Ratio (VMR): From LC–MS/MS Technology to Clinical Decision-Making in Bone and Metabolic Health
Chairpersons: Etienne Cavalier, Nasser M. Al-Daghri
Chairpersons: Etienne Cavalier, Nasser M. Al-Daghri
17:10
MR - D9
Analytical Principles and Performance Considerations in LC–MS/MS Profiling of Vitamin D Metabolites
17:10
MR - D9
Vitamin D Metabolite Ratio as a Functional Biomarker Across Health Outcomes
17:10
MR - D9
Q&A
17:10
MR - D8
Osteoporosis Diagnosis in Intellectual Disability
Chairperson: Elena Bischoff
Chairperson: Elena Bischoff
17:10
MR - D8
The Importance of Bone Health Monitoring and Fracture Risk Prediction in Intellectual Disability: State of the Art
17:10
MR - D8
REMS Application in Individuals with Intellectual Disability
17:10
MR - D1
Bridging Science and Service: Biomarkers, Translational Models, and Equity in Implementation in the Identification and Management of Sarcopenia and Frailty
Chairpersons: Nicholas Fuggle, Manju Chandran
Chairpersons: Nicholas Fuggle, Manju Chandran
17:10
MR - D1
The Global Leadership Initiative on Sarcopenia (GLIS): Defining a Pathway into the Medical Glossary
17:10
MR - D1
Integrating imaging biomarkers and biochemical markers of sarcopenia into frailty care pathways
17:10
MR - D1
Translating Research into Service: The “Frailty in Community” Program – From Science to Real-World Care
17:10
MR - D1
Strengths-based approaches to frailty assessments in partnership with older Aboriginal and Torres Strait Islander adults
17:10
MR - D2
From Bone Fragility to Fracture: Perspectives on Diagnosis and Prevention
Chairperson: Nicola Veronese
Chairperson: Nicola Veronese
17:10
MR - D2
Fragility Fractures in Osteoporosis: Diagnostic Limitations and Early Prevention Strategies
17:10
MR - D2
Improving Fracture Prevention Through Advanced Diagnostic Tools
17:10
MR - D2
Fracture Prevention in high-risk Patients: The Clinical Role of REMS Technology
17:10
MR - D3
From Fracture to Function: A Dynamic Physiotherapy Pathway for Vertebral Fracture Recovery
Chairperson: George Ioannidis
Chairperson: George Ioannidis
17:10
MR - D3
Physical performance measures for the assessment of functional limitations in older adults with vertebral fractures
17:10
MR - D3
Applying and integrating clinical care pathways to guide personalized exercise prescriptions
17:10
MR- D4
Innovative HTA Approaches for Sarcopenia: From Economic Burden to Patient-Centered Value
Chairperson: Mickael Hiligsmann
Chairperson: Mickael Hiligsmann
17:10
MR- D4
The Economic Burden of Sarcopenia and Its Impact on Societal Costs and Quality of Life
17:10
MR- D4
Economic Evaluation and HTA Approaches to Assess Value in Sarcopenia
17:10
MR- D4
Listening the Voice of Participants in Sarcopenia Research
17:10
MR - D12
Transforming Episode Accountability Model: An Opportunity to Drive Bone Health Optimization and Fracture Liaison Service Uptake in the United States
Chairperson: Rita Roy
Chairperson: Rita Roy
17:10
MR - D12
Transforming Episode Accountability Model (TEAM): Impact on Orthopaedic, Spine, and Bone Health Clinical Practice and Opportunities to Drive Osteoporosis Diagnosis and Treatment
17:10
MR - D12
A Spine Surgeon Perspective on the Need for Spine and Bone Health Optimization and Implementation of Fracture Liaison Service Programs
Sunday April 19th - CEST Timezone
08:00 - 09:00
Non-Sponsored Symposia
08:00
MR - D9
Nutrition and Physical Exercise: Individual Roles and Synergy in Sarcopenia Management
Chairperson: Bernardo Abel Cedeño Veloz
Chairperson: Bernardo Abel Cedeño Veloz
08:00
MR - D9
Molecular Mechanisms Underlying Sarcopenia: From Basic Research to Clinical Implications
08:00
MR - D9
Nutritional Strategies for Managing Sarcopenia
08:00
MR - D9
Integrating Nutrition and Exercise: A Synergistic Approach
08:00
MR - D9
Discussion + Q&A
08:00
MR - D8
Lipoprotein (a): New evidence for Bone-Vascular axis in Osteoporosis and Atherosclerosis
Chairperson: Sekib Sokolovic
Chairperson: Sekib Sokolovic
08:00
MR - D8
Lipoprotein (a) and dentin hypersensitivity: A potential link between cardiovascular and osteoporotis risk
08:00
MR - D8
Association between lipoprotein (a), menopause and cardiovascular risk in women
08:00
MR - D8
The role of Lipoprotein (a) in Osteoporosis and Atherosclerosis: A shared inflammatory pathway
08:00
MR - D6
Rewiring Pain and Angiogenesis: Transarterial Embolization as a New Frontier for Pain Management in Osteoarthritis and Musculoskeletal Disorders
Chairpersons: Alberto Migliore, Francesco Ursini
Chairpersons: Alberto Migliore, Francesco Ursini
08:00
MR - D6
Unmet Need: Filling the Gap in Treatment-Refractory Osteoarthritis
08:00
MR - D6
Technique and Angiographic Landmarks of TAE
08:00
MR - D6
Clinical Evidence in Osteoarthritis
08:00
MR - D6
Beyond Osteoarthritis: Expanding Horizons
08:00
MR - D6
Discussion
08:00
MR - D1
Management of osteoarthritis. Novel and controversial aspects
Chairperson: Panagiotis Athanassiou
Chairperson: Panagiotis Athanassiou
08:00
MR - D1
Osteoarthritis. An old and common disease
08:00
MR - D1
Osteoarthritis. Clinical picture and pathophysiology
08:00
MR - D1
Management of osteoarthritis
08:00
MR - D1
Treatment of osteoarthritis
08:00
MR - D1
Physical treatment of osteoarthritis
08:00
MR - D2
Skeletal rare bone diseases: Focus on Mc Cune Albright and Hypophosphatasia
Chairpersons: Osvaldo Daniel Messina, Kassim Javaid
Chairpersons: Osvaldo Daniel Messina, Kassim Javaid
08:00
MR - D2
From polyostotic fibrous dysplasia to autoimmunity: A unique case of McCune-Albright syndrome with rheumatoid arthritis.
08:00
MR - D2
Hypophosphatasia in 2026: Update and therapeutic opportunities
08:00
MR- D4
Thyroid–Parathyroid Disorders: The Neglected Dimension of Bone Health
Chairpersons: Dilek Gogas Yavuz, Şansın Tüzün
Chairpersons: Dilek Gogas Yavuz, Şansın Tüzün
08:00
MR- D4
Skeletal effects of parathyroid disease
08:00
MR- D4
Thyroid Hormone Deficiency and Long-Term Skeletal Outcomes: Hypothyroidism, Subclinical Hypothyroidism
08:00
MR- D4
Endogenous and Iatrogenic Thyroid Hormone Excess: Impact on Bone Health and Fracture Risk
08:00
MR- D4
Discussion + Q&A
08:00
MR - D7
Fractures-E3 Study: Fractures in sub-Saharan Africa- epidemiology, ethnography and economic impact
Chairperson: Celia Gregson
Chairperson: Celia Gregson
08:00
MR - D7
Factors affecting hip fracture service implementation in South Africa
08:00
MR - D7
Hip fracture care pathways and the delivery of traditional bone setter treatment in The Gambia
08:00
MR - D7
Patient priorities in hip fracture management and health system factors that impact responsive care in Zimbabwe
08:00 - 09:00
MR - D3
SICOT-ESCEO-IOF Symposium: Fractures around the hip in the elderly – Importance of Co-Geriatric Management
Chairpersons: Veronika Koeppen-Ursic, Marc Hanschen
Chairpersons: Veronika Koeppen-Ursic, Marc Hanschen
08:00
MR - D3
Importance of Co-Geriatric Management in the Treatment of Fractures around
the Hip
08:00
MR - D3
Pertrochanteric Fractures – Innovations and Pitfalls
08:00
MR - D3
Femoral Neck Fractures in the Elderly – Therapeutic Options
08:00
MR - D3
Sarcopenia and Fractures around the Hip – Newest Data
08:00 - 09:00
MR - C1
ESCEO-EMAS Symposium: Menopause and bone health: From hormonal changes to clinical impact
Chairpersons: Esther Speksnijder, Fitnat Dincer
Chairpersons: Esther Speksnijder, Fitnat Dincer
08:00
MR - C1
Hormonal changes around menopause and bone health
08:00
MR - C1
Body composition through menopause and its implications on bone
08:00
MR - C1
Effect of cyclic 17-β-estradiol on bone turnover in postmenopausal women
08:00 - 09:00
MR - D12
ESCEO Symposium: Treatment of Osteoporosis: What should the target be? A call for action from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
Chairpersons: Nicholas Harvey, René Rizzoli
Chairpersons: Nicholas Harvey, René Rizzoli
08:00
MR - D12
Introduction
08:00
MR - D12
IOF-ESCEO stratified fracture risk approach: altering the osteoporosis treatment paradigm
08:00
MR - D12
Surrogate measures for osteoporosis treatment evaluation and implementation in the context of absolute fracture probability
08:00
MR - D12
Discussion and conclusions
09:00 - 10:00
Meet-The-Expert Session
09:00
MR - D8
Management of fracture risk post denosumab
09:00
MR - D9
Meeting global challenges for osteoporosis patient societies
10:00 - 12:00
Auditorium 1
Scientific Session VII
Chairpersons: Nicholas Fuggle, Şansın Tüzün, Cyrus Cooper
Chairpersons: Nicholas Fuggle, Şansın Tüzün, Cyrus Cooper
10:00
Auditorium 1
Plenary Lecture
Key challenges for global fracture prevention initiatives
Key challenges for global fracture prevention initiatives
10:30
Auditorium 1
Oral communications selected from abstracts
OC37 - BURDEN OF IMMINENT SUBSEQUENT FRACTURES IN POST-MENOPAUSAL WOMEN ACROSS MULTIPLE EUROPEAN PRIMARY CARE DATABASES
OC37 - BURDEN OF IMMINENT SUBSEQUENT FRACTURES IN POST-MENOPAUSAL WOMEN ACROSS MULTIPLE EUROPEAN PRIMARY CARE DATABASES
10:40
Auditorium 1
Oral communications selected from abstracts
OC38 - EFFECT OF DENOSUMAB ON IMPLANT SURVIVAL FOLLOWING TOTAL HIP AND KNEE ARTHROPLASTY IN OSTEOARTHRITIS PATIENTS: A REGISTRY-BASED DATA LINKAGE STUDY
OC38 - EFFECT OF DENOSUMAB ON IMPLANT SURVIVAL FOLLOWING TOTAL HIP AND KNEE ARTHROPLASTY IN OSTEOARTHRITIS PATIENTS: A REGISTRY-BASED DATA LINKAGE STUDY
10:50
Auditorium 1
Oral communications selected from abstracts
OC39 - REDUCING PRE-OPERATIVE DELAY IN NECK OF FEMUR FRACTURE (NOFF) PATIENTS
OC39 - REDUCING PRE-OPERATIVE DELAY IN NECK OF FEMUR FRACTURE (NOFF) PATIENTS
11:00
Auditorium 1
Oral communications selected from abstracts
OC40 - LIFESTYLE AND CLINICAL FACTORS ASSOCIATED WITH FEMORAL NECK BONE MINERAL DENSITY IN AFRICAN ADULTS: FINDINGS FROM THE FRACTURE-E3 STUDY
OC40 - LIFESTYLE AND CLINICAL FACTORS ASSOCIATED WITH FEMORAL NECK BONE MINERAL DENSITY IN AFRICAN ADULTS: FINDINGS FROM THE FRACTURE-E3 STUDY
11:10
Auditorium 1
Oral communications selected from abstracts
OC41 - EXPLORING THE RELATIONSHIP BETWEEN BONE FORMATION AND RESORPTION CREATING BONE BALANCE INDEX FORMULAE IN ADULTS USING KIDNEY-INDEPENDENT BONE TURNOVER MARKERS
OC41 - EXPLORING THE RELATIONSHIP BETWEEN BONE FORMATION AND RESORPTION CREATING BONE BALANCE INDEX FORMULAE IN ADULTS USING KIDNEY-INDEPENDENT BONE TURNOVER MARKERS
11:30
Auditorium 1
Plenary Lecture
Imaging-based opportunistic detection for fracture prevention
Imaging-based opportunistic detection for fracture prevention
12:00 - 13:00
Non-Sponsored Symposia
12:00
MR - C1
Importance of differentiated fall risk assessment between outpatients and institutionalized patients: Fall and fracture risk program in nursing homes for elderly people
Chairperson: Oslei de Matos
Chairperson: Oslei de Matos
12:00
MR - C1
Importance of differentiated fall risk assessment between outpatients and institutionalized patients
12:00
MR - C1
Fall risk assessment and prevention program in nursing homes
12:00
MR - D9
Translating Intrinsic Capacity (IC) into Action: Measurement, Risk Stratification, and Implementation of Personalized Care Models
Chairpersons: Yasser El Miedany, Naglaa Gadallah
Chairpersons: Yasser El Miedany, Naglaa Gadallah
12:00
MR - D9
Standardizing the Measure of Moving, Thinking, and Feeling: Validating Assessment Tools for the Five Domains of Intrinsic Capacity
12:00
MR - D9
The IC Prognosticator: Using Intrinsic Capacity Profiles to Stratify Risk for Frailty, Hospitalization, and Negative Health Outcomes
12:00
MR - D9
From Concept to Clinic: Implementing Multidomain, Personalized Interventions Based on Intrinsic Capacity in Real-World Primary Care Settings
12:00
MR - D8
Dynapenia or Oral Health Assestment Tool (OHAT) on hip fractured patients?
Chairperson: Hugo Gutierrez Hermosillo
Chairperson: Hugo Gutierrez Hermosillo
12:00
MR - D8
Dynapenia (HGS) & fractures.
12:00
MR - D8
OHAT, the facts.
12:00
MR - D8
Dynapenia (HGS) Vs. OHAT, the Trial.
12:00
MR - D12
Quantitative Bone Ultrasound Techniques - Current Knowledge and Future Directions
Chairpersons: David Reid, Claus Glüer
Chairpersons: David Reid, Claus Glüer
12:00
MR - D12
The Role of Quantitative Ultrasound in Bone Health Assessment: A Historical Overview
12:00
MR - D12
Ultrasound for Fracture Prediction
12:00
MR - D12
New Approaches and Measurement Techniques
12:00
MR - D1
Breast cancer and osteoporosis
Chairperson: Ifigenia Kostoglou-Athanassiou
Chairperson: Ifigenia Kostoglou-Athanassiou
12:00
MR - D1
Breast cancer and bone metabolism
12:00
MR - D1
Breast cancer and osteoporosis
12:00
MR - D1
Adjuvant treatment of breast cancer and osteoporosis
12:00
MR - D1
Management of osteoporosis in breast cancer patients
12:00
MR - D2
Burning Bones Across Ages: Igniting Awareness about SAPHO and CRMO
Chairpersons: Wafa Hamdi, Hanene Ferjani
Chairpersons: Wafa Hamdi, Hanene Ferjani
12:00
MR - D2
Non-Infectious Bone Inflammation Through the Ages: One Disease, Multiple Faces
12:00
MR - D2
Chronic Non-bacterial Osteitis and Its Mimics: Imaging the Enigma
12:00
MR - D2
Towards a tailored therapeutic approach to SAPHO/CRMO: what does the future hold?
12:00
MR- D4
Breaking the Burden of Shoulder Pain: Advances in Diagnosis and Treatment
Chairpersons: Özlen Peker, Ece Cinar
Chairpersons: Özlen Peker, Ece Cinar
12:00
MR- D4
The Burden of Shoulder Pain
12:00
MR- D4
Assessment and Diagnostic Approach of Shoulder Pain
12:00
MR- D4
Treatment Pathways in Shoulder Pain: Pharmacological Management
12:00
MR- D4
Rehabilitation of Shoulder Pain-Related Conditions
12:00
MR - D7
Osteosarcopenia and Falls
Chairpersons: Ifigeneia Kostoglou-Athanassiou, Yannis Dionyssiotis
Chairpersons: Ifigeneia Kostoglou-Athanassiou, Yannis Dionyssiotis
12:00
MR - D7
Introduction in osteosarcopenia and falls
12:00
MR - D7
Exercise and falls: Protocols from world falls guidelines
12:00
MR - D7
Questionnaires as a tool for falls prevention in osteosarcopenia
12:00
MR - D3
The i-MOAD Symposium: Transforming Healthcare for Older Malaysians with Knee Osteoarthritis and Diabetes Mellitus
Chairperson: Sumaiyah Mat
Chairperson: Sumaiyah Mat
12:00
MR - D3
Double Burden, Single Patient: Barriers to Physical Activity in Older Adults with Knee Osteoarthritis and Type 2 Diabetes
12:00
MR - D3
Management of Knee Osteoarthritis in Older Adults with Diabetes Mellitus in Low Resource Setting: A Qualitative study among Malaysian Healthcare Providers.
12:00
MR - D3
Development of complex intervention for Older Malaysians living with Osteoarthritis with Diabetes Mellitus (i-MOAD) study
12:00
MR - D3
Q&A